Antimicrobials cost as much to develop as other drugs, but don’t earn the same returns. Congress could give drugmakers a boost, but time is running out.Thanks for listening to WIRED. Check back in tomorrow to hear more stories from WIRED.com.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Fler avsnitt av What's New
Visa alla avsnitt av What's NewWhat's New med WIRED finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
